• Academy
    • Find lectures & contributors
    • Webinars on-demand
    • Online courses
    • 89th EAS Congress, Helsinki 2021
  • Publications
  • Become an EAS member
    Sign in
    • Academy
      • Find lectures & contributors
      • Webinars on-demand
      • Online courses
      • 89th EAS Congress, Helsinki 2021
    • Publications
    • Become an EAS member
    • Sign in

    Origin/Event: 89th EAS Congress 2021

    Will PROMINENT be really prominent?

    Who will benefit most from PCSK9i?

    Which patient needs the PCSK9 inhibitors most?

    Weight reduction and atherosclerotic benefits ; from actual evidence to future challenges

    Triglyceride Metabolism in the Liver

    Triglyceride metabolism and its clinical implications

    The Mediterranean diet, its components, and cardiovascular disease

    The role of smooth muscle cells in plaque stability

    The resistant patients with HoFH – novel approaches to reducing LDL cholesterol

    The Interface of Immune and Metabolic Responses in Atherosclerosis

    Load More

    Recent Posts

    • ASCVD and Lp(a) assessment survey among clinicians
    • EAS Annual Members’ General Assembly
    • Gene-based therapies. The next generation of Atherosclerosis treatment
    • EAS Lipid Clinic Network

    Recent Comments

      © 2022 - EAS Digital

      Report

      Harassment or bullying behavior
      Contains mature or sensitive content
      Contains misleading or false information
      Contains abusive or derogatory content
      Contains spam, fake content or potential malware

      Block Member?

      Please confirm you want to block this member.

      You will no longer be able to:

      • See blocked member's posts
      • Mention this member in posts
      • Invite this member to groups
      • Message this member
      • Add this member as a connection

      Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

      Report

      You have already reported this